Björn Erlandsson
Plus aucun poste en cours
Profil
Mr. Björn Erlandsson is a Director-Finance & Operations at Albireo Ltd.
Mr. Erlandsson was previously employed as Business Controller by LM Ericsson Telefon AB, Business Controller by SCA Molnlycke Clinical Products AB, Business Controller by Pharmacia & Upjohn, Inc., and Division Controller by Duni AB.
He received his undergraduate degree from the Stockholm School of Economics.
Anciens postes connus de Björn Erlandsson
| Sociétés | Poste | Fin |
|---|---|---|
| DUNI AB | Corporate Officer/Principal | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
| ERICSSON | Corporate Officer/Principal | - |
SCA Molnlycke Clinical Products AB
 SCA Molnlycke Clinical Products AB Medical SpecialtiesHealth Technology SCA Molnlycke Clinical Products AB provides medical and clinical products. The company is headquartered in Gothenburg, Sweden | Corporate Officer/Principal | - |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Directeur Financier/CFO | - |
Formation de Björn Erlandsson
| Stockholm School of Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ERICSSON | Electronic Technology |
| DUNI AB | Consumer Durables |
| Entreprise privées | 3 |
|---|---|
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
SCA Molnlycke Clinical Products AB
SCA Molnlycke Clinical Products AB Medical SpecialtiesHealth Technology SCA Molnlycke Clinical Products AB provides medical and clinical products. The company is headquartered in Gothenburg, Sweden | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
